Suchergebnisse - "Russo, Alessandro"

PubPharm (21)

1

RET-MAP : An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Aldea, M. | Marinello, A. | Duruisseaux, M. | +42

CommentIn: J Thorac Oncol. 2023 May;18(5):549-551. - PMID 37087114

2

Early administration of tofacitinib in COVID-19 pneumonitis : An open randomised controlled trial

enthalten in: European journal of clinical investigation | 2023

von Ferrarini, A. | Vacca, A. | Solimando, A. | +18

3

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)

enthalten in: Clinical lung cancer | 2022

von Cardona, A. | Ruiz-Patiño, A. | Recondo, G. | +36

4

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections : A Retrospective Observational Multicenter Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Tumbarello, M. | Raffaelli, F. | Giannella, M. | +42

5

Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp. : a case series

enthalten in: International journal of antimicrobial agents | 2021

von Russo, A. | Venditti, M.

6

The role of teicoplanin in the treatment of SARS-CoV-2 infection : A retrospective study in critically ill COVID-19 patients (Tei-COVID study)

enthalten in: Journal of medical virology | 2021

von Ceccarelli, G. | Alessandri, F. | Oliva, A. | +13

7

PD-1/PD-L1 checkpoint inhibitors during late stages of life : an ad-hoc analysis from a large multicenter cohort

enthalten in: Journal of translational medicine | 2021

von Santini, D. | Zeppola, T. | Russano, M. | +45

8

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Buti, S. | Bersanelli, M. | Perrone, F. | +58

CommentIn: Eur J Cancer. 2021 Sep;155:313-314. - PMID 34373189

9

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cortellini, A. | Cannita, K. | Tiseo, M. | +49

CommentIn: Eur J Cancer. 2021 Sep;155:294-295. - PMID 34364743

10

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

enthalten in: Journal for immunotherapy of cancer | 2021

von Cortellini, A. | Di Maio, M. | Nigro, O. | +58